Kourtney Kardashian Barker's supplement brand, Lemme, has faced significant scrutiny following the launch of several products, most notably an “Ozempic-style” weight-loss supplement named GLP-1 Daily. The Kar-Jenner sisters have long been associated with claims of using Ozempic for weight loss, a drug originally developed for diabetes but widely used as a weight-loss aid. Kourtney's new supplement, launched last week, capitalizes on this hype by directly referencing the GLP-1 hormone, which is mimicked by the synthetic ingredient in Ozempic to slow digestion and reduce hunger.

Lemme's GLP-1 Daily is marketed to “reduce body weight, visceral fat, and hip and waist circumference.” While the brand claims it naturally increases GLP-1 levels using lemon and saffron extracts, it explicitly states it does not contain the key ingredients found in actual Ozempic. Despite this, Kourtney promoted a WWD article discussing her desire to be “in on the Ozempic boom,” and brand emails described the product as “a GLP-1 solution without the side effects” of the injectable drug.

The product, priced at an eye-watering £69 for a one-time purchase or £55.23 for a monthly subscription, has drawn sharp criticism from fans and medical professionals alike. Many fans, noting Kourtney's past advocacy for body positivity, accused her of